Harnessing nearly two decades of experience, The Chase Group, Inc. offers standard-setting professional recruitment services in the Life Sciences industry. Because we work exclusively in the substantive areas of global pharmaceuticals, biotechnology, academic medicine and research, non-profits, animal health, diagnostics, medical devices and healthcare communications, our executive recruiters are focused strictly on identifying, targeting and securing the highest quality candidates skilled for these unique markets. By maintaining an extensive network of strategic contacts specific to the Life Sciences industry, The Chase Group can deliver responsive, timely and cost-effective recruitment solutions that meet our clients’ and candidates’ specialized needs.


Dedication, keen industry insight, individualized service and a competitive spirit unite in The Chase Group’s proprietary approach to recruitment, enabling us to effectively and efficiently secure the high-caliber candidates our clients require.


Much more than just an executive search firm directory, The Chase Group offers individualized services for both clients and candidates, ensuring that skills, qualifications and personalities are a precise match. For us and for our candidates, each placement signifies more than a job—it may reflect the beginning of an enduring career or the next critical step in one’s professional evolution.

"Find a job you love and never work another day in your life..."

Oct 24, 2014

The Chase Group Fills Key Leadership Role for Cambridge BioMarketing

The Chase Group is proud to announce the completion of a search for Creative Director/Copy for Cambridge BioMarketing. This key role drives strategy and execution for the agency’s work with rare and orphan drug clients.

Oct 23, 2014

Ipsen Biosciences Retains The Chase Group for Neuroendocrine Position

Ipsen Biosciences has retained The Chase Group to secure a Director of Molecular and Cellular Endocrinology who will lead the company’s research programs to devise therapeutic strategies for endocrine diseases with unmet medical needs. Potential candidates should contact Joyce Tucker at...

Sep 19, 2014

Marinus Pharmaceuticals Retains The Chase Group

Marinus Pharmaceuticals has retained The Chase Group to secure a Chief Medical Officer to lead the overall direction, planning, execution and interpretation of medical affairs, regulatory affairs and clinical research programs implemented by Marinus. Potential candidates should contact Joyce Tucker...

Aug 28, 2014

TCG Continues Successful Collaboration with Isis Pharmaceuticals

The Chase Group announces the recruitment of Dr. Fred Derosier as Executive Director, Clinical Development. Dr. Derosier is excited to join such a dynamic organization, and TCG appreciates the opportunity to work together with Isis to expand their team of top-performing clinical development...

Aug 28, 2014

Durata Therapeutics and The Chase Group Partner Once Again

Durata Therapeutics has retained The Chase Group to secure two Executive Directors of Clinical and Medical Affairs to join their rapidly expanding clinical development team. For more information, please contact Joyce at 913.663.3100.

Aug 28, 2014

Ipsen US Retains The Chase Group

Ipsen US has retained The Chase Group to secure a VP Neurology Franchise to lead sales and marketing strategy development for commercializing products. Visionary and execution focused leaders with a proven track record will be considered for this high-profile role. Potential candidates should...

May 27, 2014

ImClone Retains The Chase Group

The early phase oncology group at Imclone is seeking a physician/scientist with immunology experience to join their team. The Chase Group has been contracted to fulfill the search. For more information about the position, please contact Moira by calling 913.663.3100.

May 19, 2014

TCG Continues Successful Collaboration with AbbVie in Building Their Global Regulatory Group

The Chase Group announces the recruitment of Dr. Steve Engel and Dr. Monique Small as Global Regulatory Leads at AbbVie’s Chicago headquarters. Ken Allison remarked, “Working on these particular searches has been a great experience, and it is our pleasure to present Steve and Monique, extremely...

May 12, 2014

Chase and Lilly Diabetes Come Full Circle

The Chase Group has been retained to identify a diabetes/insulin expert to report into a physician who was recruited by Chase at Lilly over ten years ago! TCG appreciates the continued partnership with Eli Lilly and looks forward to another successful recruitment in the near future.

Apr 17, 2014

Eli Lilly Retains The Chase Group

The search has begun for a thoracic expert to join the medical affairs team at Eli Lilly, and the company has entrusted this focused endeavor to Moira and the team at The Chase Group.